Agnieszka Maszewska

Title: Agnieszka Maszewska: Innovator in Bacteriophage Therapy

Introduction

Agnieszka Maszewska is a prominent inventor based in Lodz, Poland. She has made significant contributions to the field of bacteriophage therapy, particularly in combating drug-resistant bacterial infections. Her innovative work has the potential to revolutionize treatment options for urinary tract infections.

Latest Patents

Agnieszka holds a patent for "Bacteriophage strains against Proteus mirabilis and use thereof." This invention covers new bacteriophage strains that are specifically targeted against bacteria of the species Proteus mirabilis. The patent includes strains deposited with the Polish Collection of Microorganisms under access numbers F/00084 (72APm5211), F/00085 (39APmC32), and F/00086 (65APm2833). The bacteriophage strains are intended for use in prophylaxis and therapy, particularly against drug- and multidrug-resistant strains of the species. The preparations can be formulated in gel or liquid form and may be used in combination with other antibacterial agents.

Career Highlights

Agnieszka is affiliated with the University of Lodz, where she conducts her research and development in bacteriophage therapy. Her work is characterized by a strong focus on innovative solutions to combat bacterial infections, especially those that are resistant to conventional antibiotics.

Collaborations

Agnieszka collaborates with her coworker, Antoni Rozalski, to further advance their research in bacteriophage therapy. Their combined expertise enhances the potential for developing effective treatments against resistant bacterial strains.

Conclusion

Agnieszka Maszewska's contributions to bacteriophage therapy represent a significant advancement in the fight against antibiotic-resistant infections. Her innovative approach and dedication to research hold promise for improving therapeutic options in the medical field.